---
title: "Bausch + Lomb Corporation (BLCO.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BLCO.US.md"
symbol: "BLCO.US"
name: "Bausch + Lomb Corporation"
industry: "Health Care Supplies"
datetime: "2026-05-20T09:37:18.362Z"
locales:
  - [en](https://longbridge.com/en/quote/BLCO.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BLCO.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BLCO.US.md)
---

# Bausch + Lomb Corporation (BLCO.US)

## Company Overview

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | US Market |
| Website | [www.bausch.com](https://www.bausch.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:15.000Z

**Overall: C (0.56)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 15 / 45 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 7.85% |  |
| Net Profit YoY | 39.50% |  |
| P/B Ratio | 0.91 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 5775888999.60 |  |
| Revenue | 5208000000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -3.44% | D |
| Profit Margin | -4.21% | D |
| Gross Margin | 61.17% | A |
| Revenue YoY | 7.85% | C |
| Net Profit YoY | 39.50% | B |
| Total Assets YoY | 2.62% | C |
| Net Assets YoY | 0.30% | C |
| Cash Flow Margin | -155.25% | E |
| OCF YoY | 7.85% | C |
| Turnover | 0.38 | C |
| Gearing Ratio | 53.18% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Bausch + Lomb Corporation",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "7.85%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "39.50%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.91",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "5775888999.60",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "5208000000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-3.44%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-4.21%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "61.17%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "7.85%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "39.50%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "2.62%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "0.30%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-155.25%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "7.85%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.38",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "53.18%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -26.37 | 41/45 | - | - | - |
| PB | 0.91 | 10/45 | 0.93 | 0.86 | 0.78 |
| PS (TTM) | 1.11 | 12/45 | 1.20 | 1.10 | 1.03 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Essilor (ESLOY.US) | B | B | C | B | B | B |
| 02 | HOYA Corporation (HOCPY.US) | A | C | B | A | B | B |
| 03 | Align (ALGN.US) | B | C | B | B | C | B |
| 04 | Lantheus (LNTH.US) | A | C | B | C | C | B |
| 05 | Merit Medical (MMSI.US) | B | B | B | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-15T04:00:00.000Z

Total Analysts: **14**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 3 | 21% |
| Overweight | 1 | 7% |
| Hold | 9 | 64% |
| Underweight | 1 | 7% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 16.20 |
| Highest Target | 21.00 |
| Lowest Target | 16.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/BLCO.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/BLCO.US/norm.md)
- [Related News](https://longbridge.com/en/quote/BLCO.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/BLCO.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**